AU7724398A - A melanoma associated antigen, t cell epitopes thereof and methods of using sa me - Google Patents

A melanoma associated antigen, t cell epitopes thereof and methods of using sa me

Info

Publication number
AU7724398A
AU7724398A AU77243/98A AU7724398A AU7724398A AU 7724398 A AU7724398 A AU 7724398A AU 77243/98 A AU77243/98 A AU 77243/98A AU 7724398 A AU7724398 A AU 7724398A AU 7724398 A AU7724398 A AU 7724398A
Authority
AU
Australia
Prior art keywords
methods
associated antigen
cell epitopes
melanoma associated
melanoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77243/98A
Inventor
Robert J Deans
June Kan-Mitchell
Boris R. Minev
Malcolm S. Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of Southern California USC
Original Assignee
University of California
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of Southern California USC filed Critical University of California
Publication of AU7724398A publication Critical patent/AU7724398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/46449—Melanoma antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
AU77243/98A 1997-06-06 1998-06-04 A melanoma associated antigen, t cell epitopes thereof and methods of using sa me Abandoned AU7724398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87094197A 1997-06-06 1997-06-06
US08870941 1997-06-06
PCT/US1998/011533 WO1998055133A1 (en) 1997-06-06 1998-06-04 A melanoma associated antigen, t cell epitopes thereof and methods of using same

Publications (1)

Publication Number Publication Date
AU7724398A true AU7724398A (en) 1998-12-21

Family

ID=25356376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77243/98A Abandoned AU7724398A (en) 1997-06-06 1998-06-04 A melanoma associated antigen, t cell epitopes thereof and methods of using sa me

Country Status (2)

Country Link
AU (1) AU7724398A (en)
WO (1) WO1998055133A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795415B1 (en) * 1999-06-28 2003-09-05 Roussy Inst Gustave PEPTIDE COMPOUND DERIVED FROM AN OFFSET ORF OF THE ICE GENE
CA2516128A1 (en) * 2003-02-14 2004-09-02 Sagres Discovery, Inc. Therapeutic targets in cancer
AT502292B1 (en) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology MELANOMA DIAGNOSIS
WO2007096142A2 (en) * 2006-02-22 2007-08-30 Philogen Spa Vascular tumor markers
CN114920822B (en) * 2021-02-02 2023-06-30 复旦大学附属中山医院 T cell receptor for recognizing C7orf50 mutant antigen short peptide and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2158455C (en) * 1993-03-17 2003-05-27 Nicholas P. Restifo Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins

Also Published As

Publication number Publication date
WO1998055133A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
AU2395895A (en) Melanoma antigens
AU9231998A (en) Antigen presenting mesenchymal stem cells
AU4518196A (en) Adjuvant-incorporated cellular antigens: conjugation and methods
AUPO390396A0 (en) Novel promiscuous T helper cell epitopes
AU1281399A (en) Multi-well single-membrane permeation device and methods
AU1704099A (en) Monoclonal human natural antibodies
AU4643596A (en) Chimeric antibodies comprising antigen binding sites and b and t cell epitopes
AU1703999A (en) User interface for voice message access
AU6146596A (en) Lower-energy hydrogen methods and structures
AU8063798A (en) Secretory immunoglobulin produced by single cells and methods for making and using same
AU7422496A (en) NM03 antibody materials and methods
AU3159499A (en) Antigen preparation and use
AU7724398A (en) A melanoma associated antigen, t cell epitopes thereof and methods of using sa me
AU8892698A (en) Method for methane conversion
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU2539697A (en) Anti-idiotypic antibody vaccines
AU1108400A (en) Antigenic epitopes with lym-1 reactivity and uses thereof
AU6736598A (en) Methods for selecting cells and their uses
AU8225398A (en) Biosensor materials and methods
AU5915998A (en) Battery belt assembly and related methods
AU1749397A (en) Mycobacterium antigens and methods for their detection
AU5412498A (en) Water-decomposition gas generating device
AU2793297A (en) Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same
AU9753098A (en) Biopesticide: materials and methods
AU9649198A (en) Enclosed cell

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase